BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8112965)

  • 21. [Clinical risk factors of vitreoretinal proliferations in rhegmatogenous retinal detachment].
    Bonnet M
    J Fr Ophtalmol; 1994; 17(8-9):530-40. PubMed ID: 7989662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental scar membranes in the rabbit's vitreous. An autoradiographic and quantitative morphological study.
    Hitchins CA; Grierson I
    Acta Ophthalmol (Copenh); 1985 Oct; 63(5):557-66. PubMed ID: 4072636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation therapy in proliferative vitreoretinopathy. A prospective randomized study.
    Binder S; Bonnet M; Velikay M; Gerard JP; Stolba U; Wedrich A; Hohenberg H
    Graefes Arch Clin Exp Ophthalmol; 1994 Apr; 232(4):211-4. PubMed ID: 8034208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The lack of an effect of intraocular steroids on irradiated fibroblasts in experimental proliferative vitreoretinopathy.
    Chandler DB; Hida T; Rozakis G; Forbes VS; Machemer R
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(2):188-91. PubMed ID: 1577303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantation of fibroblasts into vitrectomized eyes. Dose-response relationship and the putative inhibitory effect of sodium hyaluronate.
    Algvere P; Landau IM
    Ophthalmic Res; 1987; 19(5):271-6. PubMed ID: 3438045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of cellular proliferation in an experimental model of massive periretinal proliferation.
    Fastenberg DM; Diddie KR; Dorey K; Ryan SJ
    Am J Ophthalmol; 1982 May; 93(5):565-72. PubMed ID: 7081355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The risk factors of proliferative vitreoretinopathy after operation of retinal detachment].
    Li C
    Yan Ke Xue Bao; 1992 Jun; 8(2):83-7. PubMed ID: 1299606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proliferative vitreoretinopathy and chemotherapeutic agents.
    Peyman GA; Schulman J
    Surv Ophthalmol; 1985; 29(6):434-42. PubMed ID: 3892742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy.
    Stern WH; Lewis GP; Erickson PA; Guerin CJ; Anderson DH; Fisher SK; O'Donnell JJ
    Am J Ophthalmol; 1983 Jul; 96(1):33-42. PubMed ID: 6869478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The chemoattractant activity of the vitreous to human scleral fibroblasts following retinal detachment and proliferative vitreoretinopathy.
    Wilson-Holt N; Khaw P; Savage F; Grierson I
    Br J Ophthalmol; 1992 Mar; 76(3):159-62. PubMed ID: 1540560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posterior vitreous separation and retinal detachment induced by macrophages.
    Hui YN; Sorgente N; Ryan SJ
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(4):279-84. PubMed ID: 3653723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preretinal membrane formation in rabbit eyes after intravitreal transplantation of cultured astrocytes.
    Mishima N; Yamashita H; Ishii Y; Hori S
    Jpn J Ophthalmol; 1989; 33(4):501-18. PubMed ID: 2696800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further observations on the prevention of experimental proliferative vitreo-retinopathy by 5-fluorouracil.
    Ophir A
    Ophthalmic Res; 1991; 23(3):128-32. PubMed ID: 1945284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental perforating injury with high energy electrons to inhibit intraocular proliferation.
    Velikay M; Binder S; Stolba U; Wedrich A; Datlinger P; Handl-Zeller L
    Acta Ophthalmol (Copenh); 1994 Jun; 72(3):337-40. PubMed ID: 7976264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aphakic retinal detachment.
    Hawkins WR
    Ophthalmic Surg; 1975; 6(2):66-74. PubMed ID: 1153162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of breakdown of the blood-retinal barrier in cell-injection models of proliferative vitreoretinopathy.
    Sen HA; Robertson TJ; Conway BP; Campochiaro PA
    Arch Ophthalmol; 1988 Sep; 106(9):1291-4. PubMed ID: 3415556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of clinical factors that predispose patients to proliferative vitreoretinopathy in aphakia.
    Nagasaki H; Ideta H; Uemura A; Morita H; Ito K; Yonemoto J
    Retina; 1991; 11(2):204-7. PubMed ID: 1925083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental traction retinal detachment in the cat.
    Wilson CA; Khawly JA; Hatchell DL; Machemer R
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(6):568-73. PubMed ID: 1765300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of vitrectomy for proliferative diabetic retinopathy.
    Thompson JT; de Bustros S; Michels RG; Rice TA; Glaser BM
    Ophthalmology; 1986 Dec; 93(12):1571-4. PubMed ID: 2433657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. X-irradiation in the prevention of experimental post-traumatic vitreous proliferation.
    Belkin M; Avni I; Kessler E; Hercberg A; Spierer A; Treister G
    Curr Eye Res; 1982-1983; 2(11):753-6. PubMed ID: 7186856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.